Retracted: Methotrexate in the treatment of symptomatic knee osteoarthritis: Randomised placebo-controlled trial

Annals of the Rheumatic Diseases

Volumn 77, Issue 7, 2018, Pages

  Abou Raya, A ^a,b   Abou Raya, S ^a,b   Khadrawe, T ^a  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b Ramleh Station Square   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETRACTION NOTICE;

EID: 85054776901     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204856     Document Type: TB

References (21)

1. Hunter DJ, Felson DT. Osteoarthritis. BMJ 2006;332:639–42.
2. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010;6:625–35.
3. Samuels J, Krasnokutsky S, Abramson SB. Osteoarthritis: A Tale of Three Tissues. Bull NYU HospJt Dis 2008;66:244–50.
4. Shibakawa A, Aoki H, Mauko-Hongo K, et al. Presence of pannus-like tissue on osteoarthritic cartilage and its histological character. Osteoarthritis Cartilage 2003;11:133–40.
5. Pelletier JP, Martel-Pelletier J, Abramson SB. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 2001;44:1237–47.
6. Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis. Part 1: Critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage 2007;15:981–1000.
7. Ranganathan P, Brinker RR. Methotrexate pharmacogenetics in rheumatoid arthritis. Clin Exp Rheumatol 2010;28(Suppl 61):S33–9.
8. Conaghan PG, Rhodes L, Hensor EM, et al. MRI study of the extent of ‘Gold-Standard’ evaluated synovitis and its relationship to pain in osteoarthritis of the knee. Arthritis Rheum 2006;5(Suppl):S822.
9. Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986;29:1039–49.
10. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494–502.
11. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159–74.
12. Bellamy N, Buchanan WW, Goldsmith CH, et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833–40.
13. Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv 1976;6:493–508.
14. Molenberghs G, Kenward MG. Missing data in clinical studies. Chichester: John Wiley & Sons; 2007.
15. Pham T, van der Heijde D, Altman RD, et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004;12: 389–99.
16. Charlson M, Szatrowski TP, Peterson J, et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47:1245–51.
17. Abou-Raya S, Abou-Raya A, Sallam N. Methotrexate: A therapeutic option in symptomatic knee osteoarthritis: randomized placebo-controlled trial. Ann Rheum Dis 2012;71(Suppl3):415.
18. Pavelka K. Methotrexate in the treatment of erosive OA of the hands. Ann Rheum Dis 2006;65:402.
19. Wenham CYJ, Grainger AJ, Hensor EM, et al. Methotrexate for pain relief in knee osteoarthritis: an open label study. Rheumatol 2013;52:888–92.
20. Cronstein B. How does methotrexate suppress inflammation? Clin and Experiment Rheumatol 2010;28(Supp 6):S21–3.
21. Scanzello CR, McKeon B, Swain BH, et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationshi to symptoms. Arthritis Rheum 2011;63:391–400.